Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
2014 · PLoS Genetics · 177 citations
https://doi.org/10.1371/journal.pgen.1004271
F
Florian Eisner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
2.1K
Citations
14
h-index
17
i10-index
Florian Eisner is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Cancer Cells and Metastasis & Genomic variations and chromosomal abnormalities. The author has an h-index of 14, co-authored 56 publications.
Papers by this author
worksCombined metformin-associated lactic acidosis and euglycemic ketoacidosis
2017 · Wiener klinische Wochenschrift · 24 citations
https://doi.org/10.1007/s00508-017-1251-6
Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma
2013 · British Journal of Cancer · 23 citations
https://doi.org/10.1038/bjc.2013.165
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis
2022 · Clinical Genitourinary Cancer · 14 citations
https://doi.org/10.1016/j.clgc.2022.03.010
Erratum: Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable as well as inoperable pancreatic cancer
2013 · British Journal of Cancer · 10 citations
https://doi.org/10.1038/bjc.2013.591
A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options
2015 · Journal of Clinical Pathology · 6 citations
https://doi.org/10.1136/jclinpath-2015-202996
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat